Pamukcuoglu M, Baysal NA, Pepeler MS. The infection rate in new diagnosis and relapsed/refractory multiple myeloma patients who had bortezomib-based chemotherapy and relationship between development of infection and lymphocyte/monocyte ratio. Eur Res J [Internet]. 2021 Nov. 3 [cited 2026 Apr. 6];7(6):541-9. Available from: https://eurj.org.tr/article/view/527